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Abstract
Background: Although obesity is a well-known risk factor for adverse pregnancy outcomes, evidence is sparse
about the effects of interpregnancy weight change on the risk of adverse perinatal complications in a subsequent
pregnancy. The current study aims to assess the effect of interpregnancy weight change on the risk of developing
gestational diabetes, pre-eclampsia, pregnancy induced hypertension, preterm birth, or delivering a large- or small-
for-gestational age neonate.
Methods: Pubmed, Ovid Embase, ClinicalTrial.gov and the Cochrane library were systematically searched up until
July 24th, 2019. Interpregnancy weight change was defined as the difference between pre-pregnancy weight of an
index pregnancy and a consecutive pregnancy. Inclusion criteria included full text original articles reporting quantitative
data about interpregnancy weight change in multiparous women with any time interval between consecutive births
and the risk of any perinatal complication of interest. Studies reporting adjusted odds ratios and a reference group of − 1
to + 1 BMI unit change between pregnancies were harmonised by meta-analysis.
Results: Twenty-three cohort studies identified a total of 671,906 women with two or more consecutive pregnancies.
Seven of these studies were included in the meta-analysis (280,672 women). Interpregnancy weight gain was consistently
associated with a higher risk of gestational diabetes, pre-eclampsia, pregnancy induced hypertension and large-
for-gestational age births. In contrast, interpregnancy weight loss was associated with a lower risk of delivering a
large-for-gestational age neonate. The effect magnitude (relative risk) of interpregnancy weight gain on pregnancy
induced hypertension or delivering a large-for-gestational age neonate was greater among women with a normal BMI
in the index pregnancy compared to women with a starting BMI ≥25 kg/m2.
Conclusion: These findings confirm that interpregnancy weight change impacts the risk of developing perinatal
complications in a subsequent pregnancy. This provides evidence in support of guidelines encouraging women
to achieve post-partum weight loss, as their risk of perinatal complications might be minimised if they return to
their pre-pregnancy weight before conceiving again.
Prospectively registered with PROSPERO (CRD42017067326).
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Background
Obesity is an increasing global health concern, with
more than 1.9 billion adults worldwide being overweight
[1] and approximately one in two US women of child-
bearing age now being considered overweight or obese
[2]. Considerable evidence exists showing serious peri-
natal complications associated with obesity in pregnancy
including gestational diabetes (GDM), pre-eclampsia
(PE) and neonatal death [3]. There is also an increased
risk of complications such as fetal growth restriction and
preterm birth amongst underweight women [4]. How-
ever, evidence is sparse about the effect of interpreg-
nancy weight change on the risk of adverse outcomes in
subsequent pregnancies. Current NICE guidelines in the
UK recommend that overweight or obese women are re-
ferred for weight loss support at the 6–8 week postnatal
check-up [5] despite limited evidence to support wide-
spread implementation of such health promotion strat-
egies and of benefit for future pregnancy outcomes [6].
The current study aimed to systematically synthesise the
published evidence on the associations between interpreg-
nancy weight change and common perinatal complica-
tions for both mother and child including GDM, PE,
pregnancy induced hypertension (PIH), preterm birth
(PTB), and delivery of a large- and small-for-gestational
age neonate (LGA and SGA). Additionally, we compared
the risk of these complications after interpregnancy weight
change in women with a normal BMI and overweight or
obese women, and where possible, we investigated the
dose-response relationships.
Methods
Eligibility criteria, information sources, search strategy
The electronic databases PubMed, Ovid EMBASE, Clini-
calTrials.gov and Cochrane Central were systematically
searched until July 24th, 2019. The search strategy
included terms relating to ‘interpregnancy’, ‘between
pregnancy’, ‘weight change’ or ‘BMI’. These search terms
were combined with the outcomes of interest (‘gestational
diabetes’, ‘pre-eclampsia’, ‘pregnancy-induced hyperten-
sion’, ‘preterm birth’, ‘small-for-gestational age’ and ‘large-
for-gestational age’) and synonyms of these outcomes (for
full search string see Additional file 3: Table S1). Further-
more, we cross-referenced selected papers for additional
articles to include. The studies identified were uploaded
onto Covidence, an online tool for screening of papers for
Fig. 1 Flow diagram of study inclusion and exclusion
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systematic reviews (www.covidence.org). The review
protocol was designed a priori and registered with PROS-
PERO under registration number CRD42017067326.
Study selection
Studies were selected using the following predetermined
inclusion criteria: [i] interpregnancy weight change re-
ported in kilogram (kg), BMI units (kg/m2) or percentage
body weight change in multiparous women with any time
interval between the consecutive births, [ii] any of the
perinatal outcomes of interest in the subsequent preg-
nancy, and [iii] observational, cohort or case-controlled
human study design with a sample size ≥50, that were
reported in English. When studies reported data from
overlapping study populations, the study with the largest
sample size was selected for inclusion. Information
extracted from each study included country of research,
study cohort name (if applicable), study period, sample
size, study inclusion criteria, methods of weight reporting,
definition of reference group, diagnostic criteria for
perinatal outcomes and demographics that studies ad-
justed for. All study selection, full text screening, and data
extraction was undertaken independently by two re-
searchers (NEWDT and KLM), following PRISMA guide-
lines [7]. Disagreements were decided through a third
opinion (AMW).
Data synthesis
Interpregnancy weight change was defined as the differ-
ence between pre-pregnancy weight in the index
Fig. 2 Forest plot from random effects meta-analysis showing the association between interpregnancy weight change and the risk of developing
gestational diabetes in subsequent pregnancy. All adjusted odds ratios are relative to the reference category of interpregnancy weight change
between − 1 and + 1 BMI units. BMI, body mass index (in kg/m2); aOR, adjusted odds ratio; CI, confidence interval
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pregnancy, defined as the earliest recorded pregnancy,
and pre-pregnancy weight in the subsequent pregnancy.
Interpregnancy weight gain and loss were defined on
two categorical scales; (i) for the meta-analysis we uti-
lised categories of > 1 BMI unit interpregnancy weight
loss, BMI gain between 1 and 2 units, BMI gain between
2 and 3 units or BMI gain of more than 3 units and (ii)
for the dose-response analysis we utilised a BMI change
of 0, 1, 2 or 3+ units. Crude odds ratios (calculated from
studies providing relevant counts) and adjusted odds
ratios for each outcome of interest were extracted from
the selected publications.
Random effects meta-analysis was used to synthesize
the odds ratios for weight change categories. To ensure
a consistent reference group, only studies that employed
a reference group of interpregnancy weight change be-
tween 1-unit weight loss and 1-unit weight gain were in-
cluded. Heterogeneity was assessed using the I2 statistic.
We conducted a separate analysis comparing inter-
pregnancy weight change and the risk of developing
adverse perinatal outcomes in women with a normal
BMI (< 25 kg/m2) versus women with an overweight
BMI (≥25 kg/m2), at the start of their index pregnancy.
To do so, adjusted odds ratios for both BMI categories
were extracted from the publications and summarised
by random effects meta-analysis.
Dose-response relationships were assessed by plotting
association measurements from studies providing mul-
tiple weight gain categories. Where ranges of BMI
changes were reported, the midpoint of the category was
Fig. 3 Forest plot from random effects meta-analysis showing the association between interpregnancy weight change and the risk of developing
pre-eclampsia in subsequent pregnancy. All adjusted odds ratios are relative to the reference category of interpregnancy weight change between
− 1 and + 1 BMI units. BMI, body mass index (in kg/m2); aOR, adjusted odds ratio; CI, confidence interval
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used (e.g. 1.5 BMI units change for the category weight
change between 1 and 2 BMI units).
Statistical analysis and graphical presentation were
performed using the metafor package in R for Windows,
version 3.4.2.
Assessment of risk of bias
A sensitivity analysis was undertaken to assess po-
tential impact of bias in individual studies by exclud-
ing studies that scored below 5 out of 9 points in
the Newcastle-Ottawa Scale (NOS [8]) quality scor-
ing assessment (Additional file 4: Table S2). Further-
more, leave-one-study-out analyses were conducted
to identify whether one study leveraged the overall
effect size estimate.
Results
Study selection
We identified and screened 4500 unique publications
and included 194 articles for full text review (Fig. 1). A
total of 27 studies were eligible for inclusion. Three
studies were excluded due to overlapping study popula-
tions [9–11] and one was excluded because of a sample
size < 50 women [12]. From the remaining 23 studies
selected to take forward, a total of 671,906 women were
identified for inclusion in the review (Table 1). Eighteen
studies included only nulliparous women at the index
pregnancy. The proportion of women older than 35
years varied between studies from 3 to 33%. All studies
were conducted in Western populations, although this
was not an inclusion criterion. Seven studies, comprising
of 280,672 women, were included in the meta-analysis.
Fig. 4 Forest plot from random effects meta-analysis showing the association between interpregnancy weight change and the risk of developing
pregnancy induced hypertension in subsequent pregnancy. All adjusted odds ratios are relative to the reference category of interpregnancy
weight change between − 1 and + 1 BMI units. BMI, body mass index (in kg/m2); aOR, adjusted odds ratio; CI, confidence interval
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Synthesis of results
Interpregnancy weight gain of between 1 and 2 BMI
units was associated with a 51% higher risk of develop-
ing GDM (aOR 1.51 [1.22–1.80], I2 = 70.1%), whereas an
increase of 2–3 or more than 3 BMI units was associated
with an 81 and 137% higher risk (aOR 1.81 [1.20–2.41],
I2 = 88.4% and aOR 2.37 [1.50–3.34], I2 = 91.0% respect-
ively) (Fig. 2). Furthermore, interpregnancy weight gain
of more than 3 BMI units was associated with a higher
risk of PE or PIH (aOR 1.70 [1.50–1.91], I2 = 0.0% and
aOR 1.71 [1.51–1.91] I2 = 0.0% respectively) (Figs. 3 and 4).
The association between interpregnancy weight change
and the risk of delivering an LGA neonate could only
be estimated for a weight gain > 3 BMI units, and
showed a 63% higher risk (aOR 1.63 [1.30–1.97], I2 =
85.6%) (Fig. 5). In contrast, interpregnancy weight loss
of > 1 BMI unit was associated with a lower risk of
delivering an LGA neonate, (aOR 0.79 [0.58–0.99], I2 =
86.1%) (Fig. 5), but there was no conclusive evidence of
association of interpregnancy weight loss with the risk
of developing GDM, PE or PIH (Figs. 2, 3 and 4). There
was an insufficient number of studies to conduct a
meta-analysis on adjusted odds ratios for the outcomes
of SGA and PTB. A meta-analysis combining the crude
odds ratios rather than adjusted ratios showed a signifi-
cant higher risk of developing PE (cOR 1.31 [1.09–
1.53], I2 = 75.1%), but showed similar results for the
association between interpregnancy weight gain and the
risk of developing GDM, PE or PIH (Additional file 1:
Figure S1 for interpregnancy weight loss and Add-
itional file 2: Figure S2 for weight gain). For the out-
comes of SGA and PTB, meta-analyses of crude odds
Fig. 5 Forest plot from random effects meta-analysis showing the association between interpregnancy weight change and the risk of delivering
a large-for-gestational age neonate in subsequent pregnancy. All adjusted odds ratios are relative to the reference category of interpregnancy
weight change between − 1 and + 1 BMI units. BMI, body mass index (in kg/m2); aOR, adjusted odds ratio; CI, confidence interval
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ratios showed interpregnancy weight loss of > 1 BMI
unit was associated with a higher risk of delivering a
SGA neonate or delivering preterm (cOR 1.53 [1.35–
1.71], I2 = 0.0% and cOR 1.45 [1.21–1.69], I2 = 26.7%]
respectively), but there was no evidence of association
with interpregnancy weight gain (Additional file 1:
Figure S1 and Additional file 2: Figure S2).
Figures 6, 7 and 8 show the odds ratios for the risk of
developing an adverse perinatal outcome after interpreg-
nancy weight gain, stratified by BMI category in the
index pregnancy (normal weight; BMI < 25 kg/m2 versus
overweight; BMI ≥25 kg/m2). Women with a normal
weight at the start of the index pregnancy had a higher
risk of developing GDM after interpregnancy weight
Fig. 6 Forest plot from random effects meta-analysis showing association between interpregnancy weight change and the risk of developing
gestational diabetes, stratified by BMI category at the start of index pregnancy. a Normal weight classified as BMI < 25 kg/m2; b Overweight
classified as BMI ≥25 kg/m2. All adjusted odds ratios are relative to the reference category of interpregnancy weight change between − 1 and + 1
BMI units. BMI, body mass index (in kg/m2); aOR, adjusted odds ratio; CI, confidence interval
Fig. 7 Forest plot from random effects meta-analysis showing association between interpregnancy weight change and the risk of delivering a
large-for-gestational age neonate, stratified by BMI category at the start of index pregnancy. a Normal weight classified as BMI < 25 kg/m2; b
Overweight classified as BMI ≥25 kg/m2. All adjusted odds ratios are relative to the reference category of interpregnancy weight change between
− 1 and + 1 BMI units. BMI, body mass index (in kg/m2); aOR, adjusted odds ratio; CI, confidence interval
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gain > 3 BMI units (aOR 4.36 [2.29–6.44], I2 = 81.6%)
compared to women with an overweight BMI (aOR 2.26
[1.40–3.12], I2 = 74.4%) (Fig. 6a and b). Similarly, women
with a BMI < 25 kg/m2 were at higher risk of delivering
a LGA neonate after interpregnancy weight gain > 3
BMI units than women with BMI ≥25 kg/m2 (aOR 1.80
[1.24–2.35], I2 = 87.2% versus aOR 1.50 [1.35–1.66], I2 =
0.0% respectively) (Fig. 7a and b). Women with a normal
BMI at the start of their index pregnancy were at higher
risk of developing PIH in a subsequent pregnancy after
interpregnancy weight gain of 2–3 BMI (aOR 1.60 [1.04–
2.16, I2 = 54.6%) and > 3 BMI units (aOR 2.21 [1.81–2.60],
I2 = 0.0%), compared to women with an overweight BMI
(2–3 units gain; aOR 0.95 [0.73–1.17], I2 = 0.0%, > 3 units
gain; aOR 1.37 [1.16–1.59], I2 = 0.0%) (Fig. 8a and b). We
did not find differential effects of interpregnancy weight
loss between women with a normal BMI and women with
an overweight BMI on the risk of developing GDM, PIH
or delivering an LGA neonate.
There was an approximate log-linear association between
interpregnancy weight gain and the risk of developing
GDM (Fig. 9a), PE (Fig. 9b) or PIH (Fig. 9c) and delivering
a LGA neonate (Fig. 9d).
Risk of bias of included studies
After assessing the study selection criteria, comparability
of cases and controls and outcome assessments through
the NOS, we identified four studies of poor quality
(NOS score < 5, Additional file 4: Table S2). However, as
these studies did not employ a reference group of ±1
BMI unit, they were already excluded from the meta-
analyses. Leave-one-out-analyses showed that removing
the study by Villamor et al. made the association between
GDM and interpregnancy weight change of 2–3 or > 3
BMI units not significant. We did not find evidence that
the outcomes for PE or PIH were driven by one study. For
the outcome of delivering an LGA neonate, leave-one-out
analyses could not be conducted due to only two studies
being included in the meta-analysis.
Discussion
Main findings
This study systematically summarises and examines the
published literature on the associations between inter-
pregnancy weight change and several common perinatal
outcomes. Our main findings are that interpregnancy
weight gain is associated with a higher risk of developing
GDM, PE, PIH and delivering an LGA neonate, while
interpregnancy weight loss is associated with a lower risk
of delivering an LGA neonate. BMI at the start of the
index pregnancy possibly modifies the risk of developing
GDM, PIH or delivering an LGA neonate after inter-
pregnancy weight gain. Furthermore, we identify a posi-
tive approximately log-linear relationship between
interpregnancy weight gain and the risk of developing
GDM, PE, PIH or delivering a LGA neonate.
Comparison with existing literature
Our study confirms the associations between inter-
pregnancy weight gain and the risk of developing
GDM and LGA, as also shown in a recent meta-
analysis [13]. Our research additionally summarises
Fig. 8 Forest plot from random effects meta-analysis showing association between interpregnancy weight change and the risk of developing
pregnancy induced hypertension, stratified by BMI category at the start of index pregnancy. a Normal weight classified as BMI < 25 kg/m2; b
Overweight classified as BMI ≥25 kg/m2. All adjusted odds ratios are relative to the reference category of interpregnancy weight change between
− 1 and + 1 BMI units. BMI, body mass index (in kg/m2); aOR, adjusted odds ratio; CI, confidence interval
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the effect of interpregnancy weight change on the risk
of developing hypertensive disorders in pregnancy.
However, our meta-analysis is to the authors know-
ledge the first study to show that gaining weight be-
tween pregnancies increases the risk of developing
hypertensive disorders in the subsequent pregnancy.
The observation that starting BMI possibly modifies
this association is important for women with a
healthy BMI at the start of their index pregnancy, as
research often emphasises the risk associated with be-
ing overweight or obese, and women with a healthy
BMI might not be aware of the risk that comes with
(small) interpregnancy weight gain. Although the risks of
(excessive) gestational weight gain [14] and high pre-
pregnancy BMI [15, 16] on perinatal outcomes are well
understood, the effects of interpregnancy weight gain are
relatively unknown and are essential to understand in
order to guide women in periconception and perinatal
weight management.
Our study shows an approximate log-linear association
between BMI gain and the risk of developing GDM or
hypertensive disorders in pregnancy. This result contrib-
utes towards understanding the association between
maternal weight and pregnancy complications. Linear
dose-response associations are established between obes-
ity and the incidence of GDM, PE and PIH [17], between
adiposity and pre-eclampsia [18], as well as maternal
weight and pre-eclampsia [15] and GDM [16]. Our iden-
tified associations emphasise the detrimental effects of
(small amounts of) weight gain, additional to the influ-
ence of absolute BMI. This can contribute towards
understanding the importance of postpartum weight
management and highlights the need for the develop-
ment of clinical guidelines.
Fig. 9 Dose-response curve with line of best fit for the increase in odds ratio of developing perinatal complications after interpregnancy weight
gain. a Gestational Diabetes. b Pre-eclampsia. c Pregnancy Induced Hypertension d Large-for-gestational age. Where ranges of BMI changes were
reported, the midpoint category was utilised (e.g. 1.5 BMI units change for the category weight change between 1 and 2 BMI units). aOR,
adjusted odds ratio. BMI, body mass index (in kg/m2)
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Strengths and limitations
A strength of our study is we ensured a homogenous
reference group (i.e. a BMI change ≤1 kg/m2) for our
meta-analysis rather than including studies with very
different reference groups [13]. Furthermore, we only
harmonised studies reporting adjusted odds ratios, which
all considered maternal age, country of origin, social
economic status and smoking status as potential con-
founders. Nevertheless, our study has several limitations.
First, between-study heterogeneity remained, arising
from differences in outcome definitions and demograph-
ics, such as parity and age, and potentially differences in
length of interpregnancy intervals and prevalence of
perinatal complications. Of the studies selected for
meta-analysis, only Lynes et al. did not restrict to
nulliparous women, although removing this study had
little impact on the results. Second, GDM, PE and
PIH were either not defined in publications or the
definitions of these adverse outcomes differed be-
tween studies, hence caution is needed when compar-
ing effect estimates between studies. Third, it was not
possible to consistently assess the impact of previous
pregnancy complications, which may lead to excessive
interpregnancy weight changes and a higher risk of
subsequent pregnancy complications. Fourth, studies
varied in the way they measured pre-pregnancy
weight, with the majority of studies using self-
reported weight (and height) to calculate BMI and
interpregnancy weight change. Although evidence sug-
gests that maternal reports of pre-pregnancy weight
are in general consistent with clinical records [42],
bias due to systematic over- or underreporting cannot
be excluded. We can also not exclude the possibility
of publication bias, as this could not be assessed due
to the small number of studies available per adverse
outcome and funnel plot assessment is generally not
recommended with less than 10 studies [43]. Lastly,
we were unable to make the distinction between
spontaneous preterm birth and medically induced
preterm birth. We hypothesise that an increased risk
of preterm birth is at least partly related to the in-
creased risk of carrying an SGA neonate, as (sus-
pected) growth restriction is one of the main causes
of medically induced premature birth [44]. However,
inadequate nutrition in the context of severe maternal
weight loss could also contribute to a higher risk of
both SGA and preterm birth [45].
Conclusions
Our study highlights the importance of postpartum
weight management, but also identifies opportunities
for future research. There is a need to capture the
typical weight change profiles of women in various
BMI classes, to further elucidate risk groups. This will
support further research into weight management
strategies, eventually aiming to implement evidence-
based weight control interventions to benefit maternal
and offspring health. It is particularly important to
elucidate strategies for postpartum weight loss in nor-
mal weight women, as this group might not be the
focus of current research and interventions, yet may
be at highest risk of adverse outcomes from inter-
pregnancy weight gain.
In conclusion, we show that interpregnancy weight
gain impacts on the risk of developing perinatal
complications in a subsequent pregnancy and it is
possible that BMI at the index pregnancy modifies these
associations. These findings highlight the need to encour-
age women to return to their pre-pregnancy weight before
conceiving again in an effort to reduce the risk of perinatal
complications. Future work should focus on defining the
most effective strategies to achieve this outcome.
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